Next Article in Journal
Advances in the Genetics of Hypertension: The Effect of Rare Variants
Next Article in Special Issue
p53 as a Dichotomous Regulator of Liver Disease: The Dose Makes the Medicine
Previous Article in Journal
Chronic Administration of Hydroxyurea (HU) Benefits Caucasian Patients with Sickle-Beta Thalassemia
Previous Article in Special Issue
HepPar1-Positive Circulating Microparticles Are Increased in Subjects with Hepatocellular Carcinoma and Predict Early Recurrence after Liver Resection
Article Menu
Issue 3 (March) cover image

Export Article

Open AccessReview
Int. J. Mol. Sci. 2018, 19(3), 682;

The Role of Long Non-Coding RNAs in Hepatocarcinogenesis

Institute of Pathology, University Hospital Basel, 4031 Basel, Switzerland
Department of Biomedicine, University of Basel, 4056 Basel, Switzerland
These authors contributed equally to this work.
Author to whom correspondence should be addressed.
Received: 2 February 2018 / Revised: 23 February 2018 / Accepted: 24 February 2018 / Published: 28 February 2018
(This article belongs to the Collection Molecular Mechanisms of Human Liver Diseases)
Full-Text   |   PDF [1483 KB, uploaded 8 March 2018]   |  


Whole-transcriptome analyses have revealed that a large proportion of the human genome is transcribed in non-protein-coding transcripts, designated as long non-coding RNAs (lncRNAs). Rather than being “transcriptional noise”, increasing evidence indicates that lncRNAs are key players in the regulation of many biological processes, including transcription, post-translational modification and inhibition and chromatin remodeling. Indeed, lncRNAs are widely dysregulated in human cancers, including hepatocellular carcinoma (HCC). Functional studies are beginning to provide insights into the role of oncogenic and tumor suppressive lncRNAs in the regulation of cell proliferation and motility, as well as oncogenic and metastatic potential in HCC. A better understanding of the molecular mechanisms and the complex network of interactions in which lncRNAs are involved could reveal novel diagnostic and prognostic biomarkers. Crucially, it may provide novel therapeutic opportunities to add to the currently limited number of therapeutic options for HCC patients. In this review, we summarize the current status of the field, with a focus on the best characterized dysregulated lncRNAs in HCC. View Full-Text
Keywords: long non-coding RNA; hepatocellular carcinoma; liver cancer; carcinogenesis long non-coding RNA; hepatocellular carcinoma; liver cancer; carcinogenesis

Graphical abstract

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Supplementary material


Share & Cite This Article

MDPI and ACS Style

Lanzafame, M.; Bianco, G.; Terracciano, L.M.; Ng, C.K.Y.; Piscuoglio, S. The Role of Long Non-Coding RNAs in Hepatocarcinogenesis. Int. J. Mol. Sci. 2018, 19, 682.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top